Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-23

    Virtual Booth

    An Enquiry

    Menu

    Calypsol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 314Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    PharmaTher Secures Key US Patent for Ketamine in ALS
    PharmaTher Secures Key US Patent for Ketamine in ALS

    24 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/24/3104168/0/en/PharmaTher-Secures-Key-US-Patent-for-Ketamine-in-Amyotrophic-Lateral-Sclerosis-ALS-Bolstering-its-Orphan-Drug-Designated-Program-and-Targeting-a-Billion-Dollar-Market.html

    GLOBENEWSWIRE
    24 Jun 2025
    Share Share
    NRx Pharmaceuticals files National Priority Voucher for Ketamine
    NRx Pharmaceuticals files National Priority Voucher for Ketamine

    23 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-announces-filing-of-commissioners-national-priority-voucher-application-for-intravenous-ketamine-nrx-100-302487956.html

    PR NEWSWIRE
    23 Jun 2025
    Share Share
    NRx Pharmaceuticals files ANDA for Preservative-Free IV Ketamine
    NRx Pharmaceuticals files ANDA for Preservative-Free IV Ketamine

    05 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-files-abbreviated-new-drug-application-anda-for-preservative-free-iv-ketamine-302474014.html

    PR NEWSWIRE
    05 Jun 2025
    Share Share
    PharmaTher Launches KetaVault™ to Speed Up Ketamine Research
    PharmaTher Launches KetaVault™ to Speed Up Ketamine Research

    14 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/14/3081112/0/en/PharmaTher-Unveils-KetaVault-A-First-of-Its-Kind-Portal-to-Accelerate-Ketamine-Research-and-Commercialization.html

    GLOBENEWSWIRE
    14 May 2025
    Share Share
    Alar Pharmaceuticals Begins Study of ALA-3000 for TRD Depression
    Alar Pharmaceuticals Begins Study of ALA-3000 for TRD Depression

    14 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/alar-pharmaceuticals-announces-first-patient-dosing-in-a-study-of-ala-3000-extended-release-ketamine-injection-for-treatment-resistant-depression-trd-302454659.html

    PR NEWSWIRE
    14 May 2025
    Share Share
    NRx Pharmaceuticals Files Patent for NRX-100, IV Ketamine
    NRx Pharmaceuticals Files Patent for NRX-100, IV Ketamine

    05 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-files-patent-application-for-nrx-100-its-proprietary-preservative-free-formulation-of-iv-ketamine-302445755.html

    PR NEWSWIRE
    05 May 2025
    Share Share